You are here
Biomarkers and Diagnostics
Diagnostic, prognostic and predictive biomarkers and diagnostic tools and methods are available for licensing and/or collaborative development.
Highly accurate and robust multiplexed sequencing assay for the stratification of tissue/tumours into microsatellite instability high (MSI-H) vs microsatellite instability suppressed (MSS) subtypesRead more
ORACLE is a new genetic test that combines machine learning with our understanding of tumour evolution to distinguish high- and low-risk lung tumours; it is also applicable to other tumours.Read more
The Cox-2 Inflammatory Signature is a novel pan-cancer immuno-oncology predictive biomarker with strong proof of concept data on overall patient survival predictions across various malignancies.Read more
We are seeking a commercial partner interested in pursuing the co-development or licensing of our imaging tracer 18F-FPIA.Read more
CRUK is seeking a partner to collaborate on a proprietary technology better able to identify mutational patterns in cancer genomes for patient stratification.Read more